NCT07044557View on ClinicalTrials.gov

MeDex: No Perioperative Dexamethasone in Brain Metastases

NANot yet recruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Brain Metastases
Interventions
OTHER

Withholding perioperative Dexamethasone

Patients will not receive perioperative Dex before, during, and up to 3 weeks after surgery.

All Listed Sponsors
lead

University of Louisville

OTHER

NCT07044557 - MeDex: No Perioperative Dexamethasone in Brain Metastases | Biotech Hunter | Biotech Hunter